返回
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.（02315.HK）价格
02315.HK 股价走势图
BIOCYTOGEN-B (02315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$39.72
-8.22%
$-3.56
休市： Jan 19, 16:00:00 HKT
关键数据
前收盘价
$43.28
开盘价
$43.28
当日区间
$39 - $43.28
52周范围
$7.07 - $39.72
交易量
2.3M
平均成交量
689.4K
每股收益（TTM）
0.37
股息收益率
--
市值
$4.2B
什么是 BIOCYTOGEN-B？
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.